FreeS Fund Wins 12 Awards, Thanks to Recognition from 36Kr, ChinaVenture, FOFWEEKLY, Cyzone, and 21st Century Business Herald | FreeS Fund
Continuously Hiring Investors
"FreeS Dispatch" is our periodic roundup of news and updates from FreeS Fund — events, job openings, partnership opportunities, and more. We look forward to having you join us in doing work that's meaningful and interesting, and in witnessing innovation and the extraordinary in business.
This edition at a glance:
- Recognition received: 36Kr named FreeS Fund and founding partner Feng Li among top investors in frontier tech, chips/semiconductors, and cross-border expansion; Feng Li ranked in ChinaVenture's "Top 50 Best Early-Stage Investors of 2020"; FreeS Fund placed 6th in China FOF Research Center's "Top 30 Early-Stage Funds with Earliest Returns 2021"; FreeS Fund ranked 8th in Cyzone's "2021 China's Most Admired Early-Stage Investment Firms"; FreeS Fund named among the "Top 10 Early-Stage Investment Firms in Healthcare Investment Competitiveness 2020-2021" by 21st Century Business Herald and 21st Century Innovation Capital Research Institute.
- FreeS Fund hosted an offline event for portfolio CEOs in Shenzhen: "FreeS Open Talk." We've also released a short video capturing the event — follow us to check it out.
- FreeS Fund is hiring investors in deep tech, biotech, and consumer/TMT across Beijing, Shanghai, and Shenzhen, as well as interns in investment research, legal, finance, HR (portfolio support), and video content operations. Send your resume directly to hr@freesvc.com anytime.
01
Recent Recognition
▍FreeS Fund and founding partner Feng Li recognized by 36Kr for investments in frontier tech, chips/semiconductors, and cross-border expansion
On September 24, 36Kr released its 2021 rankings of investment firms and investors across eight sectors of China's innovation economy: healthcare, consumer, enterprise services, frontier tech, chips/semiconductors, cross-border expansion, new-style dining, and logistics/supply chain. (Read the full report: 36Kr | 36Kr Innovation Economy 8 Sectors Investment Firm/Investor Rankings and China Equity Investment Market Report (2020-2021))
▍Feng Li named to ChinaVenture's "Top 50 Best Early-Stage Investors of 2020"
On September 24, ChinaVenture released its 2020 rankings, unveiling awards including "Best Venture Capital Investor," "Best Private Equity Investor," "Best Early-Stage Investor," "Best Industry Investor," and "Best Return Investor." Feng Li, founding partner of FreeS Fund, was named to the "Top 50 Best Early-Stage Investors of 2020."
The ChinaVenture rankings draw on CVSource data, evaluating investors on their investments, exits, portfolio management, and industry influence between July 1, 2018 and June 30, 2021. Through questionnaire surveys, interviews, data verification, and standardization, the rankings cover over 1,200 investors from more than 300 firms, offering a comprehensive measure of market dynamics and competitive landscape. (Read more: ChinaVenture | ChinaVenture 2020 Investor Rankings Released)
▍FreeS Fund ranks 6th in China FOF Research Center's "Top 30 Early-Stage Funds with Earliest Returns 2021"
On September 26, China FOF Research Center released its mid-2021 rankings to recognize outstanding institutions and talent in the private equity fund-of-funds and fund management industry, and to promote the healthy development of equity investment. FreeS Fund was named to the "Top 30 Early-Stage Funds with Earliest Returns 2021," ranking 6th. (Read more: China FOF Research Center | China FOF Research Center 2021 Mid-Year Rankings Unveiled)
▍FreeS Fund ranks 8th in Cyzone's "2021 China's Most Admired Early-Stage Investment Firms"
On September 22, Cyzone released its annual lists of "China's Most Admired Venture Capital Firms" and "China's Most Admired Early-Stage Investment Firms." FreeS Fund was named to the latter, ranking 8th.
To compile this list, Cyzone Research invited 200 judges — all seasoned investors, many of whom had previously appeared on Cyzone's various rankings including annual investors, young investors, female investors, and angel investors. (Read more: Cyzone | Who Are China's Most Admired VC Firms?)
▍FreeS Fund named among "Top 10 Early-Stage Investment Firms in Healthcare Investment Competitiveness 2020-2021" by 21st Century Business Herald and 21st Century Innovation Capital Research Institute
On September 29, 21st Century Business Herald and 21st Century Innovation Capital Research Institute released their "2020-2021 Healthcare Investment Competitiveness" case studies. FreeS Fund was named among the "Top 10 Early-Stage Investment Firms in Healthcare Investment Competitiveness 2020-2021."
From among the many investment firms focused on healthcare, the research team conducted surveys, interviews, and questionnaires with hundreds of firms, collecting data on fundraising, healthcare investments, exits, and follow-on rounds for portfolio companies. They also referenced third-party data from CVSource and iFinD, and incorporated ESG considerations from an expert panel. (Read more: 21st Century Innovation Capital Research Institute | 2020-2021 21st Century Equity Investment Competitiveness Healthcare Sector Case Studies Released)
02
Recent Events
"FreeS Open Talk" is an intimate offline gathering for CEOs in the FreeS family. We invite experts and seasoned FreeS portfolio CEOs to share insights and practical experience on topics that matter to our founders.
This past Q3, we welcomed Yang Linlin, founder of Duozhou and CEO coach. In 2016, she began studying ByteDance's growth and documenting its management practices as a startup. In 2020, she provided management research services to ByteDance. She has also advised companies including Genki Forest, Shejian Technology, and ArcSoft on OKR implementation and organizational design.
At the event, Yang Linlin joined nearly 20 founders and executives to share her thinking and methodology on the theme "When Business Grows Fast, How Do You Keep the Team Aligned?"
Click the video above to revisit highlights from the event 👆
Thanks to ACC Super Accessories, a FreeS portfolio company, for providing the venue.
03 Open Positions
For six years, FreeS Fund has chosen to do what's right rather than what's easy, staying firmly bullish on Chinese innovation. We want to invite more people to join us as we enter our seventh year. Today, we've evolved into a full-cycle fund management company driven by early-stage investing, with active positions in growth and late-stage deals. Across consumer/TMT, deep tech, and biotech, we've invested in over 150 innovative companies.
Our portfolio includes listed companies such as Three Squirrels, 360 DigiTech, Uber Global, and Unity, as well as numerous high-growth innovators including Qingtao Development, XtalPi, Patpat, Coyote Bioscience, Yifei Automation, Saturnbird, Yanming Biotech, and Singleron.
We're hiring investors in deep tech, biotech, and consumer/TMT in Beijing, Shanghai, and Shenzhen. If you have an industry background and an interest in investing, we'd love to hear from you — and we welcome referrals too. (For full job descriptions, click the "read more" link at the end of this article.)
Please send your resume to hr@freesvc.com
*Email subject line: Application for "[Biotech / Tech / Consumer] Investor" — "[City]"
We're also hiring interns in investment research, legal, finance, HR (portfolio support), and video content operations. Interested students are welcome to apply. (For full job descriptions, click the "read more" link at the end of this article.)
Internship duration: 3-6 months, 3-5 days per week on-site. Based in Beijing preferred.
Please send your resume to hr@freesvc.com
*Email subject line: Position — Name — School — Major — Minimum internship duration (months) — Days per week — Earliest start date
Star our WeChat account for first-hand industry research and insights
Celebrating Six Years: We Look Forward to More Upward-Striving Talent Joining Us | FreeS Dispatch
